12k
glucagon — my 7-week log, condensed into one table
Posting this because I searched for it and got nothing useful. Setup: 0.5mg, week 48, injection-site soreness present but not ruining anything. I changed exactly one…
u/deleted_my_history
Nuked my old comments. Starting again with better habits.
member · joined 2 Oct 2024
17,891post karma
5,100comment karma
5submissions
57comments
Overview — page 3 of 4
comment on the ATTAIN thing finally clicked for me and I want to write it down in c/orforglipron · 2 points · 1 year ago
cite ATTAIN/ACHIEVE arms specifically
comment on [Results] 37 weeks, 16kg, and phase 2 was the hard part in c/retatrutide · -11 points · 1 year ago
This is correct. Triple agonism is genuinely different.
comment on [Discussion] can we stop arguing about thymosin until somebody posts a number in c/researchpeptides · -6 points · 1 year ago
Sweden here. Waited 5 months on a list, gave up, went private, and the total cost was roughly what I expected.
comment on what changed for me between week 60 and week 8 in c/orforglipron · 33 points · 1 year ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [Question] New Zealand — has anyone got a straight answer on dose escalation in c/retatrutide · 27 points · 1 year ago
Small correction: the trial was 16 weeks, not 11. Does not change your point but people will quote it.
comment on tried MASH for 10 weeks. here is what happened. in c/survodutide · 28 points · 1 year ago
Removed a chain here.
Adding to this: hepatic fat is doing more work than the comment implies.
comment on 14 months in and jurisdiction is still the thing I get wrong in c/customs · 5 points · 2 years ago
Yeah, Spain rules are not global.
Adding to this: jurisdiction is doing more work than the comment implies.
comment on the Netherlands: thymosin, and what it actually costs here in c/researchpeptides · 127 points · 2 years ago
Not convinced. The evidence does not support that reading.
comment on reading MASH threads from 2024 and half of it aged badly in c/survodutide · 21 points · 2 years ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on 20 months in and non-peptide is still the thing I get wrong in c/orforglipron · 16 points · 2 years ago
the supply conversation changes if this approves
comment on 20 months in and non-peptide is still the thing I get wrong in c/orforglipron · 41 points · 2 years ago
availability speculation must be flaired Speculation
comment on 20 months in and non-peptide is still the thing I get wrong in c/orforglipron · 6 points · 2 years ago
Stalled for 18 weeks, changed nothing, and it started moving again on week 9.
comment on 20 months in and non-peptide is still the thing I get wrong in c/orforglipron · 10 points · 2 years ago
Not to be pedantic but small molecule and oral GLP-1 are being used interchangeably and they are not interchangeable in real life.
1.8k
20 months in and non-peptide is still the thing I get wrong
ACHIEVE. That is the whole post, but I will justify it. Everything else people worry about in c/bpc157 is downstream of it. Titration speed, early fullness, the endless…
comment on [Lab] 19th independent test on QSC, and the trend is the interesting part in c/retatrutide · 67 points · 2 years ago
IANAD and neither is anyone upvoting this
comment on tried seizure for 7 weeks. here is what happened. in c/customs · 158 points · 2 years ago
Mechanistically the bit that matters is declared value. It explains most of the early profile and a decent chunk of the outcome.
comment on anyone else notice phase 2 kicking in around week 30 in c/retatrutide · 1 points · 2 years ago
heart rate and dose escalation need actual measurements, not impressions
comment on tried retatrutide for 7 weeks. here is what happened. in c/retatrutide · 3 points · 2 years ago
retatrutide is not approved anywhere for human use, posts must not read as instructions
comment on week 51 check-in — 12kg down, injection-site soreness manageable, one thing confusing me in c/retatrutide · 1 points · 2 years ago
TRIUMPH phase 2 showed 99.0% weight loss but the reflux profile on the highest arm was rough.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.